UBS Maintains Neutral on Viavi Solutions, Lowers Price Target to $44

Benzinga Newsdesk www.benzinga.com Negative 55.6%

Neg 55.6% Neu 0% Pos 0%

UBS analyst Andrew Spinola maintains Viavi Solutions (NASDAQ:VIAV) with a Neutral and lowers the price target from $60 to $44.